Minimal residual disease monitoring: the new standard for treatment evaluation of haematological malignancies?. Swiss Med Wkly [Internet]. 2014 Jan. 12 [cited 2025 Nov. 25];144(0304):w13907. Available from: https://smw.ch/index.php/smw/article/view/1811